Does OBINUTUZUMAB Cause Myalgia? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Myalgia have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.4% of all adverse event reports for OBINUTUZUMAB.
60
Reports of Myalgia with OBINUTUZUMAB
0.4%
of all OBINUTUZUMAB reports
1
Deaths
21
Hospitalizations
How Dangerous Is Myalgia From OBINUTUZUMAB?
Of the 60 reports, 1 (1.7%) resulted in death, 21 (35.0%) required hospitalization, and 1 (1.7%) were considered life-threatening.
Is Myalgia Listed in the Official Label?
Yes, Myalgia is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Myalgia?
ATORVASTATIN (7,155)
EVOLOCUMAB (5,061)
ROSUVASTATIN (3,958)
SIMVASTATIN (3,919)
ADALIMUMAB (3,134)
DUPILUMAB (3,064)
DENOSUMAB (2,965)
LEVOTHYROXINE (2,467)
CIPROFLOXACIN (2,291)
EZETIMIBE (2,066)
Which OBINUTUZUMAB Alternatives Have Lower Myalgia Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE